Results 201 to 210 of about 296,735 (290)
Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial. [PDF]
De Dios Pérez B +5 more
europepmc +1 more source
Abstract Background Children and young people with pre‐existing mental health and neurodevelopmental conditions may have experienced heterogeneous mental health impacts during the COVID‐19 pandemic, but what facts may explain these variations are still unclear. We aimed to examine variations in the longitudinal trajectories of emotional and behavioural
Brian C. F. Ching +8 more
wiley +1 more source
Back from the brink: programmed cell revival for regeneration. [PDF]
Sundaram B, Kanneganti TD.
europepmc +1 more source
Abstract This study explores how social enterprises create social and economic value through business models that support ex‐offenders. The work was motivated by a request for help from an entrepreneur wishing to establish a business that supports ex‐offender rehabilitation.
Elizabeth Green +2 more
wiley +1 more source
Reconstructing the Origin and Demographic Expansion of the TP53 p.R337H Founder Variant in Brazil. [PDF]
Pinto EM +5 more
europepmc +1 more source
Transparency in Reporting on Charities’ Efficiency
Noel Hyndman, D. Mcconville
semanticscholar +1 more source
Turning the Tables: Leveraging Purpose as a Strategic Advantage for SMEs
ABSTRACT When executed well, purpose can become a transformative force, turning a business into a breakout success. Despite the wave of purpose‐driven businesses in recent years, the concept of purpose remains underdeveloped. Purpose is a core component of business models but is difficult to retrofit into large corporations, which makes it especially ...
Klaus Heine, Glyn Atwal, Sonja Sperber
wiley +1 more source
Co-Designing End-of-Life Care for People With Pre-Existing Severe Mental Illness: Insights From Multiple Stakeholder Consultations. [PDF]
Cui J, Zheng C, Yeung CC, Chan HY.
europepmc +1 more source
New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender +2 more
wiley +1 more source
This study provides an in‐depth account of patients' experiences of drainage as a symptom of hidradenitis suppurativa. The HIDE Scale© facilitates incorporation of these insights into clinical practice, supporting person‐centred approaches that enhance clinical assessment, reduce stigma, and strengthen patient–clinician communication.
Stine Thestrup Hansen +20 more
wiley +1 more source

